Adaobi Kanu, MD
NPI 1518905934ActiveIndividual· Pediatrics, Pediatric Pulmonology· Lubbock, TX
Pediatrics, Pediatric Pulmonology (MD) in Lubbock, Texas, trained at University of Connecticut School of Medicine (class of 1996). Part D covered 292 prescriptions written in 2024, 68% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 17 companies reporting payments in 2025, $840.15 in all, mostly food and beverage.
Overview
| NPI | 1518905934 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Jun 4, 2006 |
| Last updated in NPPES | Dec 3, 2021 |
| Certified by provider | Dec 3, 2021 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Pediatrics, Pediatric Pulmonology Primary | 2080P0214X | N0874 | TX |
| Pediatrics | 208000000X | N0874 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Pulmonary Disease (TX) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 292 · 362 30-day fills |
|---|---|
| Patients | 11 |
| Total drug cost | $598,878 |
| Generic share | 68% of claims |
Education and affiliations
| Medical school | University of Connecticut School of Medicine |
|---|---|
| Graduation year | 1996 |
| Medicare specialty | Pulmonary Disease |
| Secondary specialties | Pediatric Medicine |
Medical group
- Texas Tech University Health Sciences Center LubbockLubbock, TX · 359 clinicians
Hospital affiliation
- University Medical CenterLubbock, TX
Industry payments (Open Payments)
- 2025$840.15 · 29 payments from 17 companies
- 2024$838.04 · 38 payments from 10 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $190.64 | 5 |
| Ars Pharmaceuticals Operations, Inc. | $117.29 | 1 |
| Insmed, Inc. | $84.68 | 3 |
| Genentech USA, Inc. | $74.69 | 3 |
| Genzyme Corporation | $68.92 | 2 |
What the 2025 payments were for
- Food and Beverage$840.15 · 29 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records